Pregled bibliografske jedinice broj: 910455
Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549
Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549 // Journal of enzyme inhibition and medicinal chemistry, 33 (2018), 1; 271-285 doi:10.1080/14756366.2017.1414807 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 910455 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549
Autori
Bistrović, Andrea ; Grbčić, Petra ; Harej, Anja ; Sedić, Mirela ; Kraljević Pavelić, Sandra ; Koštrun, Sanja ; Plavec, Janez ; Makuc, Damjan ; Raić-Malić, Silvana
Izvornik
Journal of enzyme inhibition and medicinal chemistry (1475-6366) 33
(2018), 1;
271-285
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
purine ; 1, 2, 3-triazole ; purinomimetic ; non-small cell lung cancer A549 ; p38 MAPK
Sažetak
Novel halogenated purines and pseudopurines with diverse aryl-substituted 1, 2, 3-triazoles were prepared. While p-(trifluoromethyl)-substituted 1, 2, 3-triazole in N-9 alkylated purine and 3- deazapurine was critical for strong albeit unselective activity on pancreatic adenocarcinoma cells CFPAC-1, 1-(p-fluorophenyl)-1, 2, 3- triazole derivative of 7-deazapurine showed selective cytostatic effect on metastatic colon cancer cells SW620. Importantly, 1-(p- chlorophenyl)-1, 2, 3- triazole-tagged benzimidazole displayed the most pronounced and highly selective inhibitory effect in nM range on non-small cell lung cancer A549. This compound revealed to target molecular processes at the extracellular side and inside the plasma membrane regulated by GPLD1 and growth factor receptors PDGFR and IGF-1R leading to the inhibition of cell proliferation and induction of apoptosis mediated by p38 MAP kinase and NF-B, respectively. Further optimization of this compound as to reduce its toxicity in normal cells may lead to the development of novel agent effective against lung cancer.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
HRZZ-IP-2013-11-5596 - Sinteza i citostatska ispitivanja biblioteke novih dušikovih heterocikla (SCIENcENTRY) (Raić-Malić, Silvana, HRZZ - 2013-11) ( CroRIS)
Ustanove:
Fakultet kemijskog inženjerstva i tehnologije, Zagreb,
Fidelta d.o.o.,
Sveučilište u Rijeci - Odjel za biotehnologiju
Profili:
Silvana Raić-Malić
(autor)
Anja Harej Hrkać
(autor)
Andrea Bistrović
(autor)
Sanja Koštrun
(autor)
Mirela Sedić
(autor)
Petra Grbčić
(autor)
Sandra Kraljević Pavelić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE